Literature DB >> 17646307

Comparative analysis of microarray normalization procedures: effects on reverse engineering gene networks.

Wei Keat Lim1, Kai Wang, Celine Lefebvre, Andrea Califano.   

Abstract

MOTIVATION: An increasingly common application of gene expression profile data is the reverse engineering of cellular networks. However, common procedures to normalize expression profiles generated using the Affymetrix GeneChips technology were originally developed for a rather different purpose, namely the accurate measure of differential gene expression between two or more phenotypes. As a result, current evaluation strategies lack comprehensive metrics to assess the suitability of available normalization procedures for reverse engineering and, in general, for measuring correlation between the expression profiles of a gene pair.
RESULTS: We benchmark four commonly used normalization procedures (MAS5, RMA, GCRMA and Li-Wong) in the context of established algorithms for the reverse engineering of protein-protein and protein-DNA interactions. Replicate sample, randomized and human B-cell data sets are used as an input. Surprisingly, our study suggests that MAS5 provides the most faithful cellular network reconstruction. Furthermore, we identify a crucial step in GCRMA responsible for introducing severe artifacts in the data leading to a systematic overestimate of pairwise correlation. This has key implications not only for reverse engineering but also for other methods, such as hierarchical clustering, relying on accurate measurements of pairwise expression profile correlation. We propose an alternative implementation to eliminate such side effect.

Entities:  

Mesh:

Year:  2007        PMID: 17646307     DOI: 10.1093/bioinformatics/btm201

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  86 in total

1.  A Novel Schema to Enhance Data Quality of Patient Safety Event Reports.

Authors:  Hong Kang; Yang Gong
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

2.  Affymetrix GeneChip microarray preprocessing for multivariate analyses.

Authors:  Matthew N McCall; Anthony Almudevar
Journal:  Brief Bioinform       Date:  2011-12-30       Impact factor: 11.622

3.  Integrating heterogeneous gene expression data for gene regulatory network modelling.

Authors:  Alina Sîrbu; Heather J Ruskin; Martin Crane
Journal:  Theory Biosci       Date:  2011-09-24       Impact factor: 1.919

4.  Low-dose pretreatment for radiation therapy.

Authors:  Richard Blankenbecler
Journal:  Dose Response       Date:  2010-09-10       Impact factor: 2.658

5.  Gene expression and genetic variation data implicate PCLO in bipolar disorder.

Authors:  Kwang H Choi; Brandon W Higgs; Jens R Wendland; Jonathan Song; Francis J McMahon; Maree J Webster
Journal:  Biol Psychiatry       Date:  2010-12-24       Impact factor: 13.382

6.  AffyTrees: facilitating comparative analysis of Affymetrix plant microarray chips.

Authors:  Tancred Frickey; Vagner Augusto Benedito; Michael Udvardi; Georg Weiller
Journal:  Plant Physiol       Date:  2007-12-07       Impact factor: 8.340

7.  Finding differentially expressed genes in two-channel DNA microarray datasets: how to increase reliability of data preprocessing.

Authors:  Ana Rotter; Matjaz Hren; Spela Baebler; Andrej Blejec; Kristina Gruden
Journal:  OMICS       Date:  2008-09

8.  A problem with the correlation coefficient as a measure of gene expression divergence.

Authors:  Vini Pereira; David Waxman; Adam Eyre-Walker
Journal:  Genetics       Date:  2009-10-12       Impact factor: 4.562

9.  Quantitative analysis of p53 expression in human normal and cancer tissue microarray with global normalization method.

Authors:  Halliday A Idikio
Journal:  Int J Clin Exp Pathol       Date:  2011-06-15

10.  Global rank-invariant set normalization (GRSN) to reduce systematic distortions in microarray data.

Authors:  Carl R Pelz; Molly Kulesz-Martin; Grover Bagby; Rosalie C Sears
Journal:  BMC Bioinformatics       Date:  2008-12-04       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.